Clinical Trial Update: Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis [Phase 2]

View source ↗

Summary

This update describes a Phase 2 study evaluating momelotinib in combination with luspatercept for transfusion-dependent myelofibrosis; the trial is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Post-essential Thrombocythemia Myelofibrosis
• Post-polycythemia Vera Myelofibrosis

Drugs mentioned

• Momelotinib (momelotinib)
• REBLOZYL (LUSPATERCEPT)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Primary Myelofibrosis, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis | Phase 2 | Status: RECRUITING